M. Yermalovich, V. Kolodkina, E. Samoilovich, G. Semeiko, A. O. Mikhalenko
{"title":"Postinfectious and Postvaccinal Humoral Immune Response to SARS-CoV-2 in Adults: Qualitative and Quantitative Assessment","authors":"M. Yermalovich, V. Kolodkina, E. Samoilovich, G. Semeiko, A. O. Mikhalenko","doi":"10.31631/2073-3046-2023-22-3-50-56","DOIUrl":null,"url":null,"abstract":"Relevance. Serological studies play an important role in assessing the spread of SARS-CoV-2 and formation of post-infection and post-vaccination immune response.The Aims aim of the study was a comparative assessment of seroprevalence and concentration of antibodies to SARS-CoV-2 at 3–6 months after infection or vaccination.Materials & Methods. For the presence of total IgM and IgG antibodies to RBD fragment of the SARS-CoV-2 S protein, the blood sera of 1331 people aged 18-70 years were examined, of which 334 had COVID-19 3–6 months before the study, 305 did not have COVID-19 and were vaccinated (using Sputnik V, Russia, or Sinopharm, PRC) 3–6 months before the study, 692 people were not ill and were not vaccinated. A quantitative assessment of IgG antibodies to the full-size S-protein of SARS-CoV-2 was performed for 435 samples.Results. The proportion of seropositive individuals 3–6 months after COVID-19 or after vaccination did not differ: 92.5% and 93.8% of the corresponding group had antibodies. Among the non-ill and unvaccinated, 45.7% also had specific antibodies, which indicates a high level of asymptomatic infection with SARS-CoV-2. The group of vaccinated was also examined immediately before the introduction of the vaccine, and 39.7% of them already had specific antibodies due to asymptomatic infection with SARS-CoV-2. The median concentration of antibodies in the group of COVID-19 was statistically significantly higher than in asymptomatically infected (50.9 AE/ml versus 29.1 AE/ml). The largest proportion of seropositive individuals (100.0%) and the highest concentration of antibodies (110 AE/ml) were detected in the group of vaccinated who had pre-existing antibodies.Conclusion. Infection with the SARS-CoV-2 is characterized by a high frequency of subclinical course. Asymptomatic infection induced a weaker immune response compared to symptomatic COVID-19 or vaccination. Hybrid immunity caused by natural infection with SARS-CoV-2 and subsequent vaccination was the most persistent and pronounced.","PeriodicalId":11736,"journal":{"name":"Epidemiology and Vaccinal Prevention","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epidemiology and Vaccinal Prevention","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31631/2073-3046-2023-22-3-50-56","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Relevance. Serological studies play an important role in assessing the spread of SARS-CoV-2 and formation of post-infection and post-vaccination immune response.The Aims aim of the study was a comparative assessment of seroprevalence and concentration of antibodies to SARS-CoV-2 at 3–6 months after infection or vaccination.Materials & Methods. For the presence of total IgM and IgG antibodies to RBD fragment of the SARS-CoV-2 S protein, the blood sera of 1331 people aged 18-70 years were examined, of which 334 had COVID-19 3–6 months before the study, 305 did not have COVID-19 and were vaccinated (using Sputnik V, Russia, or Sinopharm, PRC) 3–6 months before the study, 692 people were not ill and were not vaccinated. A quantitative assessment of IgG antibodies to the full-size S-protein of SARS-CoV-2 was performed for 435 samples.Results. The proportion of seropositive individuals 3–6 months after COVID-19 or after vaccination did not differ: 92.5% and 93.8% of the corresponding group had antibodies. Among the non-ill and unvaccinated, 45.7% also had specific antibodies, which indicates a high level of asymptomatic infection with SARS-CoV-2. The group of vaccinated was also examined immediately before the introduction of the vaccine, and 39.7% of them already had specific antibodies due to asymptomatic infection with SARS-CoV-2. The median concentration of antibodies in the group of COVID-19 was statistically significantly higher than in asymptomatically infected (50.9 AE/ml versus 29.1 AE/ml). The largest proportion of seropositive individuals (100.0%) and the highest concentration of antibodies (110 AE/ml) were detected in the group of vaccinated who had pre-existing antibodies.Conclusion. Infection with the SARS-CoV-2 is characterized by a high frequency of subclinical course. Asymptomatic infection induced a weaker immune response compared to symptomatic COVID-19 or vaccination. Hybrid immunity caused by natural infection with SARS-CoV-2 and subsequent vaccination was the most persistent and pronounced.